← FDA Drug Approvals (Drugs@FDA)

NATEGLINIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALVOGEN · Approved 2015-12-11

Drug application

FDA Application #

ANDA205055

Application type

Abbreviated New Drug Application (Generic)

Brand name

NATEGLINIDE

Generic name

Nateglinide

Active ingredients

NATEGLINIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

ALVOGEN

First approval

2015-12-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown